These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29587278)

  • 1. A Risk-Adapted Approach to Patients with Stage I Seminoma according to the Status of Rete Testis: The Fourth Spanish Germ Cell Cancer Group Study.
    Aparicio J; Sánchez-Muñoz A; Gumà J; Domenech M; Meana JA; García-Sánchez J; Bastús R; Gironés R; González-Billalabeitia E; Sagastibelza N; Ochenduszko S; Sánchez A; Terrasa J; Germà-Lluch JR; García Del Muro X;
    Oncology; 2018; 95(1):8-12. PubMed ID: 29587278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
    Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
    J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.
    Aparicio J; García Del Muro X; Maroto P; Terrasa J; Castellano D; Bastús R; Gumà J; Sagastibeltza N; Durán I; Ochenduszko S; Meana JA; García-Sánchez J; Arranz JA; Gironés R; Germà JR
    Clin Transl Oncol; 2021 Jan; 23(1):58-64. PubMed ID: 32462393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.
    Aparicio J; Maroto P; del Muro XG; Gumà J; Sánchez-Muñoz A; Margelí M; Doménech M; Bastús R; Fernández A; López-Brea M; Terrassa J; Meana A; del Prado PM; Sastre J; Satrústegui JJ; Gironés R; Robert L; Germà JR
    J Clin Oncol; 2011 Dec; 29(35):4677-81. PubMed ID: 22042940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG).
    Aparicio J; Maroto P; García Del Muro X; Sánchez-Muñoz A; Gumà J; Margelí M; Sáenz A; Sagastibelza N; Castellano D; Arranz JA; Hervás D; Bastús R; Fernández-Aramburo A; Sastre J; Terrasa J; López-Brea M; Dorca J; Almenar D; Carles J; Hernández A; Germà JR
    Ann Oncol; 2014 Nov; 25(11):2173-2178. PubMed ID: 25210015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
    Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rete testis invasion by malignant germ cell tumor and/or intratubular germ cell neoplasia: what is the significance of this finding?
    Vogt AP; Chen Z; Osunkoya AO
    Hum Pathol; 2010 Sep; 41(9):1339-44. PubMed ID: 20573373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.
    Bilici A; Ozturk T; Turkmen E; Odabas H; Cihan S; Selcukbiricik F; Erdogan B; Urakci Z; Kandemir N; Bayoglu IV; Demirci U; Duran AO; Sendur MA; Yavuzer D; Harputluoglu H; Kavgaci H; Gumus M
    World J Urol; 2015 Oct; 33(10):1613-22. PubMed ID: 25605506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
    Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
    Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of tumour size and rete testis invasion in progression free survival of our patients with stage i testicular seminoma. A retrospective observational study of a reference hospital center and literature review.
    Yáñez-Castillo YM; Melgarejo-Segura MT; Gutiérrez-Tejero F; Arrabal-Martín M
    Actas Urol Esp (Engl Ed); 2023 Dec; 47(10):654-660. PubMed ID: 37355209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA).
    Tandstad T; Ståhl O; Dahl O; Haugnes HS; Håkansson U; Karlsdottir Å; Kjellman A; Langberg CW; Laurell A; Oldenburg J; Solberg A; Söderström K; Stierner U; Cavallin-Ståhl E; Wahlqvist R; Wall N; Cohn-Cedermark G;
    Ann Oncol; 2016 Jul; 27(7):1299-304. PubMed ID: 27052649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective multicentre study of carboplatin monotherapy for clinical stage I seminoma.
    Steiner H; Scheiber K; Berger AP; Rein P; Hobisch A; Aufderklamm J; Pilloni S; Stoehr B; Aigner F; Fritzer A; Zangerl F
    BJU Int; 2011 Apr; 107(7):1074-9. PubMed ID: 21438975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma.
    Aparicio J; García del Muro X; Maroto P; Paz-Ares L; Alba E; Sáenz A; Terrasa J; Barnadas A; Almenar D; Arranz JA; Sánchez M; Fernández A; Sastre J; Carles J; Dorca J; Gumà J; Yuste AL; Germà JR;
    Ann Oncol; 2003 Jun; 14(6):867-72. PubMed ID: 12796024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy.
    Ondrusova M; Ondrus D; Miskovska V; Kajo K; Szoldova K; Usakova V; Stastna V
    Int Urol Nephrol; 2015 Jul; 47(7):1143-7. PubMed ID: 25982582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey.
    Diminutto A; Basso U; Maruzzo M; Morelli F; De Giorgi U; Perin A; Fraccon AP; Lo Re G; Rizzi A; Sava T; Fornarini G; Valcamonico F; Zustovich F; Massari F; Zanardi E; Roma A; Zattoni F; Zagonel V
    Clin Genitourin Cancer; 2016 Apr; 14(2):e161-9. PubMed ID: 26775721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients.
    Kamba T; Kamoto T; Okubo K; Teramukai S; Kakehi Y; Matsuda T; Ogawa O
    Int J Urol; 2010 Dec; 17(12):980-7. PubMed ID: 20955354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stage I seminoma and radiotherapy: to bury it or not?].
    Pouessel D; Culine S; Azria D
    Cancer Radiother; 2008 Dec; 12(8):842-7. PubMed ID: 18760650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboplatin for stage I seminoma and the sword of Damocles.
    Loehrer PJ; Bosl GJ
    J Clin Oncol; 2005 Dec; 23(34):8566-9. PubMed ID: 16260692
    [No Abstract]   [Full Text] [Related]  

  • 20. Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminoma.
    Reiter WJ; Brodowicz T; Alavi S; Zielinski CC; Kozak W; Maier U; Nöst G; Lipsky H; Marberger M; Kratzik C
    J Clin Oncol; 2001 Jan; 19(1):101-4. PubMed ID: 11134201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.